Black Diamond Therapeutics, Inc. (BDTX) vs Coya Therapeutics, Inc. (COYA)
A side-by-side comparison of Black Diamond Therapeutics, Inc. and Coya Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BDTX
Black Diamond Therapeutics, Inc.
$1.88HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT
COYA
Coya Therapeutics, Inc.
$5.00HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT
Total return — BDTX vs COYA
growth of $100 · dividends reinvested · last 4yBDTX +18.3% (+4.3%/yr)COYA +6.1% (+1.5%/yr)BDTX compounded faster over this window
BDTX COYA
BDTX vs COYA: by the numbers
- •COYA is the larger company ($117M vs $107M market cap).
- •BDTX is profitable (31.95% net margin) while COYA runs a net loss (-270.22%).
Metrics side by side
Valuation
| Metric | BDTX | COYA |
|---|---|---|
| P/S ratio | N/A | 14.61 |
| P/B ratio | 1.12 | 0.00 |
Profitability
| Metric | BDTX | COYA |
|---|---|---|
| Gross margin | 99.54% | 99.91% |
| Operating margin | 28.39% | -255.05% |
| Net margin | 31.95% | -270.22% |
| ROE | -44.29% | -0.05% |
| ROIC | -47.54% | -0.05% |
Growth (annualized)
| Metric | BDTX | COYA |
|---|---|---|
| Total return CAGR (5Y) | -24.47% | N/A |
Frequently asked
- Is BDTX or COYA more profitable?
- BDTX runs the higher net margin — BDTX at 31.95% versus COYA at -270.22%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.